---
title: "Biotech-KISAN: DBT Farmer Scheme Explained | Model Diplomat"
description: "Biotech-KISAN is a 2017 Indian scheme connecting farmers with scientists through innovation hubs, crucial for enhancing agricultural practices and research."
url: "https://modeldiplomat.com/learn/glossary/biotech-kisan"
---

[New](https://modeldiplomat.com/)

#

Model Diplomat Research Team · Last reviewed June 22, 2026

TL;DR

- Biotech-KISAN is an Indian government scheme launched by the Department of Biotechnology in 2017 to connect agricultural scientists with farmers through regional innovation hubs.
- Which ministry administers Biotech-KISAN, and why does that matter?
- How does Biotech-KISAN differ from a Krishi Vigyan Kendra?
- What is the role of a Biotech-KISAN Hub?
- Why is Biotech-KISAN relevant for UPSC General Studies Paper III?

[Civil Service & Diplomatic Exams](https://modeldiplomat.com/learn/civil-services/glossary)Updated June 22, 2026

Go beyond the definition

## Research Biotech-KISAN like a delegate

Model Diplomat's AI drafts position papers, speeches, and country research with real sources — built for MUN and politics students.

## Positions at a glance

### Supporters

Biotech-KISAN must be distinguished from the Krishi Vigyan Kendra network, with which it is sometimes conflated. KVKs, administered through the Indian Council of Agricultural Research (ICAR) under the Ministry of Agriculture and Farmers Welfare, are permanent district-level institutions providing general agricultural extension; Biotech-KISAN, by contrast, is a DBT scheme specifically oriented toward biotechnology applications and may use a KVK as a hub anchor without being subsumed by it. It also differs from broad agricultural-income schemes such as PM-KISAN, which is a direct income-support transfer programme of the agriculture ministry and shares only the "KISAN" label, not the institutional design. Practitioners should likewise separate Biotech-KISAN from ATMA (Agricultural Technology Management Agency), which is an extension-reform mechanism rather than a science-delivery hub network.

### Opponents

Edge cases and critiques of Biotech-KISAN centre on scale and continuity. Critics observe that the hub model, while innovative, covers only a fraction of India's villages and that benefits remain concentrated where strong anchor institutions already exist, potentially widening rather than narrowing the research-access divide. Questions persist about the long-term sustainability of interventions once project funding cycles conclude, and about rigorous impact evaluation of yield and income outcomes. The scheme's reliance on biotechnology has also intersected with India's broader, sometimes contentious, regulatory debates over genetically modified crops, although Biotech-KISAN interventions have largely emphasised non-controversial technologies such as biofertilisers, tissue culture, and conventional breeding rather than transgenic crops. Periodic budgetary allocations through the DBT determine the pace of new hub sanctioning.

## Research it like a delegate

Research on modeldiplomat.com

## Ask a follow-up about Biotech-KISAN

Open a cited briefing in Model Diplomat search — timelines, positions, and sources you can use in committee or exam answers.

[Start research on Biotech-KISAN](https://modeldiplomat.com/search?q=Explain%20Biotech-KISAN%20%E2%80%94%20key%20dates%2C%20actors%2C%20positions%2C%20and%20sources)

Example

In 2017 the Department of Biotechnology sanctioned Biotech-KISAN hubs across India's agro-climatic zones, with a dedicated component for the North-Eastern states anchored by regional agricultural and scientific institutions.

Keep learning

## Go deeper than the definition

[Explore all Civil Service & Diplomatic Exams lessons](https://modeldiplomat.com/learn/civil-services)[Test yourself with a quiz](https://modeldiplomat.com/learn/glossary/quiz/civil-services)

## Take Biotech-KISAN beyond the glossary

Ask the AI research engine built for diplomacy — get briefings, position papers, and speeches with sources you can cite in committee.